Crossmark

First-time diagnosis and referral practices for individuals with CKD by primary care physicians: a study of electronic medical records across multiple clinics in Japan

Crossref DOI link: https://doi.org/10.1007/s10157-025-02695-8

Published Online: 2025-05-16

Published Print: 2025-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Uchida, Haruhito A.

Wada, Jun

Nagao, Yuji

Ihara, Katsuhito
Funding

Funding for this research was provided by:

Nippon Boehringer Ingelheim & Eli Lilly Diabetes Alliance
License Information

Text and Data Mining valid from 2025-05-16

Version of Record valid from 2025-05-16
More Information

Article History

Received: 15 November 2024

Accepted: 5 May 2025

First Online: 16 May 2025

Declarations

:

: H.A.U. belongs to the Department of Chronic Kidney Disease and Cardiovascular Disease, which is endowed by Boehringer Ingelheim, Olba Healthcare Holdings, and Terumo Corporation. J.W. has received speaker honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Kyowa Kirin, Novo Nordisk, and Mitsubishi Tanabe Pharma, and receives grant support from Bayer, Chugai, Kyowa Kirin, Otsuka, Shionogi, Sumitomo, and Mitsubishi Tanabe Pharma. Y.N. and K.I. are employees of Nippon Boehringer Ingelheim. The authors did not receive payment related to the development of the manuscript.

Document is current

Any future updates will be listed below